Vitamins China E-News

Publication: Monthly on the
Published by CCM

  Vitamins China E-News provides you with real-time intelligence on China's vitamins market.
   
  China is the world's largest exporter of vitamins, while the domestic market has also expanded rapidly in recent years thanks to growing demand from the feed and pharmaceuticals markets. Now, competition in the industry is shifting from producing API to higher-margin pharmaceutical-grade products, while China’s tougher stance on environmental protection is also having an effect.
   
  Vitamins China E-News will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamins industry chain, from raw materials to end consumption. This includes:
  
        
  •       Breaking news from China and abroad
  •     
  •       The latest market data, including price information for raw materials, intermediates and end products, import/export data, production, consumption, operating rates, etc.
  •     
  •       In-depth analysis of market trends, Chinese government policy, the performance of leading Chinese producers, M&A, new technologies, and more
  •     
  •       Expert commentary from industry insiders, including regular guest articles and interviews with insiders at leading Chinese manufacturers, associations and government organizations
  •   
  Vitamins China E-News is also available as a monthly newsletter, which can be downloaded in PDF format. For more information, you can download a free sample below, or get in touch with us directly by emailing econtact@cnchemicals.com or calling +86-20-37616606.


  • Future-issues subscription

Starting from the issue of
202011
lasting for


0.5 1 1.5 2 2.5 3


year(s)  , is priced at


  • Single user license:
    USD 2,700
  • Corporate license:
    USD 6,750

All the prices on this website exclude VAT.

<<
  • 202011
  • 202010
  • 202009
  • 202008
  • 202007
  • 202006
  • 202005
  • 202004
  • 202003
  • 202002
  • 202001
  • 201912
  • 201911
  • 201910
  • 201909
  • 201908
  • 201907
  • 201906
  • 201905
  • 201904
  • 201903
  • 201902
  • 201901
  • 201812
  • 201811
  • 201810
  • 201809
  • 201808
  • 201807
  • 201806
  • 201805
  • 201804
  • 201803
  • 201802
  • 201801
  • 201712
  • 201711
  • 201710
  • 201709
  • 201708
  • 201707
  • 201706
  • 201705
  • 201704
  • 201703
  • 201702
  • 201701
  • 201612
  • 201611
  • 201610
  • 201609
  • 201608
  • 201607
  • 201606
  • 201605
  • 201604
  • 201603
  • 201602
  • 201601
  • 201512
  • 201511
  • 201510
  • 201509
  • 201508
  • 201507
  • 201506
  • 201505
  • 201504
  • 201503
  • 201502
  • 201501
  • 201412
  • 201411
  • 201410
>>

Main Content of Vitamins China E-News 202010

Price of this issue :
USD 259

Published on 29th October, 2020

Domestic vitamin witnessed a sluggish market in Oct. Despite positive news for VB3, its price has been falling since June.

Published on 28th October, 2020

On 13 Oct., the Guidelines for Anti-monopoly in the Field of APIs (Consultation Paper) was publicized by the State Administration for Market Regulation to solicit opinions from the publish date until 30 Oct.

Published on 27th October, 2020

On 13 Oct., Kingdomway announced that its wholly-owned subsidiary, Kingdomway Pharmaceutical has obtained Food Production License for VK2 oil miscible liquid (by fermentation process).

Published on 26th October, 2020

On 28 Sept., Hongda Biological's food and feed additive project was publicized. The project is newly built for production of food and feed additive VK2 powder/oil.

Published on 26th October, 2020

Published on 26th October, 2020

Published on 21st October, 2020

Haoyuan Chemexpress noticed on 28 Sept. that its eldecalcitol and intermediate project gained outstanding innovation silver award in the 32nd Shanghai Outstanding Invention Trial and therefore aroused wide concerns.

Published on 20th October, 2020

In August, China's vitamin export suffered decreases both in volume and value. And VB1 witnessed rise in export volume (3.86% MoM) yet decline in price (10.54% MoM).

Published on 20th October, 2020

Published on 20th October, 2020

Hanshang Group and its subsidiary, Hanshang Health proposed to acquire Dikang Pharmaceutical's 100% shares with USD132.75 million (RMB900 million). After the acquisition, Dikang Pharmaceutical will become Hanshang Group's wholly-owned subsidiary.

Published on 16th October, 2020

Published on 16th October, 2020

Published on 14th October, 2020

Published on 14th October, 2020

On 28 Sept., the EIA report of Xiangmin Pharmaceutical's 15 t/a ascorbyl glucoside and 15.625 t/a NMN project gained intended approval from and was published by the Linli Environmental Protection Department of Changde City, Hunan Province.

Published on 13th October, 2020

On 9 Oct., Arawana publicized its IPO prospect on the GEM, disclosing performances of Arawana and its subsidiary, Wilmar Nutrition.

Published on 13th October, 2020

EIA reports of Brother Pharmaceutical's two projects were publicized in late Sept. The projects are 13,000 t/a VB3, 3,000 t/a fragrance and intermediates project (material changes) and 2,190 t/a fragrance, 8 t/a APIs, 1,500 t/a vitamin and intermediate project.

Published on 13th October, 2020

Published on 13th October, 2020

Published on 13th October, 2020

Published on 12th October, 2020

Published on 12th October, 2020

Published on 12th October, 2020

Published on 10th October, 2020

Published on 10th October, 2020


CCM Customized Service on Market Research

Do you want Import & Export Analysis, Financial Data, Cost Analysis, Supply Chain Research etc. ? We will customize the specific research for you, in case the services listed above does not meet your precise requirements. Our product and industry research in China’s agriculture, chemicals, food & ingredients and life science markets will comprehensively cover the business information, which is able to help you arrive at strategic and profitable business decisions.

Please directly contact econtact@cnchemicals.com to specify your Market Research Requirement